INVITRO VENOUS PROSTACYCLIN PRODUCTION, PLASMA 6-KETO-PROSTAGLANDIN-F1-ALPHA CONCENTRATIONS, AND DIABETIC-RETINOPATHY

被引：59

作者：

DAVIS, TME

BOWN, E

FINCH, DR

MITCHELL, MD

TURNER, RC

机构：

[1] JOHN RADCLIFFE HOSP, NUFFIELD DEPT SURG, OXFORD OX3 9DU, ENGLAND

[2] JOHN RADCLIFFE HOSP, NUFFIELD DEPT OBSTET & GYNAECOL, OXFORD OX3 9DU, ENGLAND

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1981年 / 282卷 / 6272期

关键词：

D O I：

10.1136/bmj.282.6272.1259

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1259 / 1262

页数：4

共 22 条

[1] DAVIS TME, 1980, LANCET, V1, P373
[2] DAVIS TME, 1979, LANCET, V2, P789
[3] DEBONO D, 1975, BRIT J EXP PATHOL, V56, P8
[4] DOLLERY CT, 1979, LANCET, V2, P1365
[5] MORBIDITY AND MORTALITY IN DIABETICS IN FRAMINGHAM POPULATION - 16-YEAR FOLLOW-UP STUDY
GARCIA, MJ
MCNAMARA, PM
GORDON, T
KANNELL, WB
[J]. DIABETES, 1974, 23 (02) : 105 - 111
[6] EFFECT OF INSULIN-TREATMENT ON PROSTACYCLIN IN EXPERIMENTAL DIABETES
HARRISON, HE
REECE, AH
JOHNSON, M
[J]. DIABETOLOGIA, 1980, 18 (01) : 65 - 68
[7] DECREASED VASCULAR PROSTACYCLIN IN EXPERIMENTAL DIABETES
HARRISON, HE
REECE, AH
JOHNSON, M
[J]. LIFE SCIENCES, 1978, 23 (04) : 351 - 356
[8] JARRETT RJ, 1976, LANCET, V2, P1009
[9] JOHNSON M, 1979, LANCET, V1, P325
[10] JORGENSEN KA, 1979, LANCET, V1, P1352